Interestingly, neuropsychiatric outcomes (i.e., depression, fatigue) did not appear to be substantially different in NMDAR1-abs seropositive compared to seronegative patients at either follow-up timepoint, which is in contrast to previous study results [12, 52]. Here, GRIN1 is linked to depressive disorder.